A breakthrough drug expected to give back years to hundreds of thousands of Australians suffering through a debilitating ...

The most common form of dementia that surfaces in midlife (generally talking 40s and 50s here) is called frontotemporal ...

The FDA greenlit marketing for the first blood test to help diagnose Alzheimer’s disease. Experts believe this will increase ...

Thousands of people have paid for Dale Bredesen’s unconventional program to reverse Alzheimer’s symptoms. The medical ...

The test may make it easier to identify whether people with memory and thinking problems have Alzheimer’s or not.

The approval comes as two Alzheimer's drugs—lecanemab and donanemab—are already authorized by the FDA. Both are antibody therapies that target amyloid plaques and are believed to be more effective ...